FDA bans references to sinusitis on OTC nasal decongestants

10/12/2005 | Wall Street Journal, The

The FDA said OTC nasal decongestants no longer will be allowed to cite "sinusitis" on their products after determining there is no evidence the drugs are effective as a substitute for antibiotics, the normal treatment for a bacterial infection. In addition to drugs for colds and allergies, new regulations also are to apply to topical decongestants and nasal sprays, as well as to combination products and to generic versions of those drugs.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ